Renaissance Technologies LLC Sells 654 Shares of Chemed Co. (NYSE:CHE)

Renaissance Technologies LLC trimmed its holdings in Chemed Co. (NYSE:CHE) by 1.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,100 shares of the company’s stock after selling 654 shares during the period. Renaissance Technologies LLC’s holdings in Chemed were worth $24,954,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. UMB Bank n.a. boosted its holdings in Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atala Financial Inc acquired a new position in shares of Chemed during the 4th quarter valued at about $29,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after acquiring an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the 4th quarter valued at approximately $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock worth $41,000 after purchasing an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 0.2 %

Shares of NYSE:CHE opened at $591.44 on Friday. The business has a 50 day moving average price of $583.16 and a 200 day moving average price of $567.95. The company has a market cap of $8.64 billion, a price-to-earnings ratio of 29.89, a PEG ratio of 2.15 and a beta of 0.49. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $625.09.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s payout ratio is 10.05%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. This trade represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 3.32% of the company’s stock.

Analyst Upgrades and Downgrades

CHE has been the topic of several analyst reports. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada boosted their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.